TrialJournal of clinical hypertension (Greenwich, Conn.)2018

Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease.

George L Bakris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.